Evidence supporting the use of: Somatropin
For the health condition: Weight Gain
Synopsis
Source of validity: Scientific
Rating (out of 5): 4
Somatropin is a recombinant human growth hormone (rhGH) that is scientifically validated for use in promoting weight gain in specific clinical situations, primarily those involving growth hormone deficiency or catabolic states. In individuals with growth hormone deficiency (both children and adults), somatropin has been shown to increase lean body mass, reduce fat mass, and improve overall body composition. Its efficacy is well-established in conditions such as Turner syndrome, Prader-Willi syndrome, chronic renal insufficiency, and in patients with HIV-associated wasting. Clinical trials have demonstrated that somatropin therapy can increase muscle mass and support weight gain in these populations by stimulating protein synthesis, enhancing lipolysis, and promoting retention of nitrogen, minerals, and electrolytes.
However, somatropin is not indicated or supported for general weight gain in healthy individuals or in those seeking to gain weight for aesthetic or athletic purposes. Its use is strictly regulated due to potential side effects, including edema, arthralgia, insulin resistance, and increased risk of certain malignancies. The rating of 4 reflects strong evidence for weight gain and body composition improvement in medically indicated contexts, but not for general or non-clinical use.
Other ingredients used for Weight Gain
ashwagandhamaltodextrin
whey protein
17a-di methyl-bol
Arginine Creatine
Avocado
Animal protein
Beef Protein
Egg
glucose
Other health conditions supported by Somatropin
Acquired Immune Deficiency SyndromeAnorexia
Athletic and Exercise Aids
Burns and Scalds
Chemotherapy (reducing side effects)
Convalescence
Debility
Energy (lack of)
Exercise
Failure to Thrive
Injuries
Muscle Tone (lack of)
Muscular Dystrophy
Nerve Damage
Osteoporosis
Radiation Sickness
Surgery (healing from)
Wasting
Weight Gain
Weight Loss
Wounds and Sores